Skip to content
TrialScanner

NCT03634007

Gene Therapy for APOE4 Homozygote of Alzheimer's Disease

Phase 1/Phase 2CompletedLXEOLead

Registry record

Lead sponsor
Lexeo Therapeutics
Conditions
Alzheimer Disease; Early Onset Alzheimer Disease
Primary completion
Nov 7, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03634007 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03634007: Gene Therapy for APOE4... | TrialScanner